Press "Enter" to skip to content

New patent expiration for Takeda Pharms drug DEXILANT

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Takeda Pharms drug DEXILANT

Annual Drug Patent Expirations for DEXILANT
Annual Drug Patent Expirations for DEXILANT

Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from three suppliers. There are seventeen patents protecting this drug and two Paragraph IV challenges.

Drug patent litigation for DEXILANT.

This drug has sixty-four patent family members in twenty-five countries.

The generic ingredient in DEXILANT is dexlansoprazole. Three suppliers are listed for this compound. Additional details are available on the dexlansoprazole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Takeda Pharms drug DEXILANT
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions